Search Within

MSK Grad Students

Formats
  1. Journal Article (1632)
  2. Meeting Abstract (966)
  3. Review (105)
  4. Editorial (42)
  5. Research Letter (35)
  6. Miscellaneous (19)
  7. Correspondence (15)
  8. Conference Paper (12)
  9. Book Section (9)
  10. Guidelines (6)
Groups
  1. GSK Faculty (1992)
  2. Department of Medicine (1593)
  3. Sloan Kettering Institute Postdocs (1580)
  4. Sloan Kettering Institute Faculty (1300)
  5. Center for Hematologic Malignancies (1110)
  6. Hematologic Malignancies, Division of (994)

More Groups

People
  1. Sergio Giralt (393)
  2. Miguel-Angel Perales (377)
  3. Parastoo Dahi (294)
  4. Sean Devlin (277)
  5. Doris Ponce (254)
  6. Roni Tamari (209)

More People

Years
  1. 2025 (95)
  2. 2024 (256)
  3. 2023 (312)
  4. 2022 (334)
  5. 2021 (289)
  6. 2020 (378)

More Years

Publications
  1. Blood (294)
  2. Biology of Blood and Marrow Transplantation (165)
  3. Cancer Research (132)
  4. Journal of Clinical Oncology (127)
  5. Nature Communications (96)
  6. Nature (85)

More Publications

Publishers
  1. Nature Publishing Group (435)
  2. American Society of Hematology (331)
  3. Elsevier Inc. (298)
  4. Cell Press (272)
  5. American Association for Cancer Research (265)
  6. American Society of Clinical Oncology (143)

More Publishers

Results (2841)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Meeting Abstract

    Chen, Z.; Clinton, T. N.; Park, S.; Lenis, A. T.; Donoghue, M.; Rosenberg, J. E.; Dean, B. F.; Teo, M. Y.; Bochner, B. H.; Ostrovnaya, I.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Analysis of homologous recombination deficiency (HRD) scores in osteosarcoma
    Meeting Abstract

    Kinnaman, M. D.; Pena, J.; Levine, M.; Bouvier, N.; Papaemmanuil, E.; Forrest, S.; Janeway, K.; Meyers, P.; Bender, J. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment
    Meeting Abstract

    Yan, J.; Chen, Y.; Patel, A. J.; Lee, C. J.; Warda, S.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Molecular subtypes characterize appendiceal adenocarcinoma genomic evolution and disease behavior
    Meeting Abstract

    Foote, M. B.; Walch, H.; Chatila, W.; Vakiani, E.; Chandler, C.; Steinrucke, F.; Nash, G.; Stadler, Z.; Chung, S.; Kemel, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Meeting Abstract

    Liu, B.; Drago, J. Z.; Rao, Y.; Pereira, P. R.; Safonov, A.; Marra, A.; Ahmed, M. S.; Modi, S.; Reis, J. S.; Montemurro, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma
    Meeting Abstract

    Costa, E.; Wohlheiter, C.; Tischfield, S.; Funnell, A.; Poirier, J. T.; Villalonga, A. Q.; Sen, T.; Rudin, C.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • MCT4 blockade reverses lactate-mediated immunosuppression in LKB1-deficient NSCLC
    Meeting Abstract

    Qian, Y.; Guijarro, I.; Galan-Cobo, A.; Dang, M.; Poteete, A.; Zhang, F.; Wang, Q.; Wang, J.; Parra, E.; Skoulidis, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Characterization of genomic diversity in high grade serous ovarian and triple negative breast cancer at single cell resolution
    Meeting Abstract

    Williams, M. J.; Funnell, T.; O'Flanagan, C. H.; McPherson, A.; Aparicio, S.; Shah, S. P.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacologic inhibition of the glycolytic pathway improves response to immune checkpoint blockade
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Ko, M.; Mangarin, L.; Merghoub, T.; Wolchok, J.; Zappasodi, R.
    Cancer Research (2022)

    Fulltext@MSK | Save